Freeman Martin L
Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN 55455, USA.
Gastrointest Endosc Clin N Am. 2012 Jul;22(3):567-86. doi: 10.1016/j.giec.2012.05.001.
Endoscopic retrograde cholangiopancreatography (ERCP) is now almost exclusively a therapeutic modality for pancreatic as well as biliary disorders. ERCP alone or with associated pancreatic and biliary therapy can cause a spectrum of mild and severe complications, including pancreatitis, hemorrhage, perforation, and cardiopulmonary events. Understanding of complications of ERCP has progressed substantially in the past decade, including widespread adoption of standardized consensus-based definitions of complications, large multicenter multivariate studies that have permitted clearer understanding of patient and technique-related risk factors for complications, and introduction of new technical approaches to minimize risks of ERCP.
内镜逆行胰胆管造影术(ERCP)如今几乎完全是一种用于治疗胰腺和胆道疾病的手段。单独的ERCP或联合胰腺和胆道治疗可引发一系列轻重程度不同的并发症,包括胰腺炎、出血、穿孔及心肺事件。在过去十年中,对ERCP并发症的认识有了显著进展,包括广泛采用基于共识的标准化并发症定义、开展大型多中心多变量研究从而更清晰地了解与患者及技术相关的并发症风险因素,以及引入新的技术方法以降低ERCP的风险。